Why I went with MT-1 (pardon me repeating myself):
Which receptors it hits: MT-1 acts only on MC1R, the one tied to melanin creation. MT-2, on the other hand, latches onto MC1R plus MC3R, MC4R and MC5R. That wider reach is why MT-2 brings body-wide reactions that MT-1 does not — queasiness, a drop in hunger, shifts in mood, and effects on sexual function.
How safe it looks: MT-1 comes with a stronger paper trail on safety and fewer adverse events on record. With MT-2, queasiness is a frequent complaint, particularly as the dose climbs, and people often need something for nausea beforehand.
Protection from the sun: MT-1 gives real photoprotection and teams up with UV, cutting how much UV you need by ~50%. MT-2 will darken skin even with no UV at all, but it does not offer that shielding effect.
Where the FDA stands: For MT-1 there is an approved implant, SCENESSE®, used for uncommon medical conditions — a sign of clinical backing. MT-2 is still research-only.
Ease of dosing: With MT-1 you inject 2-3x per day, though the overall amount is smaller (0.5-1mg/day). With MT-2 it is 0.25-1mg each day, or 2-3x per week, but you deal with more side effect management.
What you give up: MT-2 throws in sexual enhancement and appetite suppression as extras; MT-1 is only about tanning and skin health.